Advancement in Thalassemia Treatment: A View from Gene Therapy

Arulmani Thiyagarajan

doi:10.4172/2167-065X.1000e131

ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Editorial
Clin Pharmacol Biopharm 2018, Vol 7(1): e131
DOI: 10.4172/2167-065X.1000e131

Advancement in Thalassemia Treatment: A View from Gene Therapy

Arulmani Thiyagarajan^*: Department of Public Health, SRM University, Chennai, Tamilnadu, India

^*Corresponding Author : Dr. Arulmani Thiyagarajan BDS MPH, School of Public Health, SRM University, Kattankulathur, Chennai, Tamilnadu, India, Tel: +919788192339, Email: arulmani.thiyagarajan@gmail.com

Received Date: Jan 25, 2018 / Accepted Date: Feb 02, 2018 / Published Date: Feb 05, 2018

View PDF Download PDF

Citation: Thiyagarajan A (2018) Advancement in Thalassemia Treatment: A View from Gene Therapy. Clin Pharmacol Biopharm 7: e131. Doi: 10.4172/2167-065X.1000e131

Copyright: ©2018 Thiyagarajan A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.